Evidence map›Paper›PMID 32788213›Full record

ReviewThe Journal of biological chemistry2020

Nuclear receptor phosphorylation in xenobiotic signal transduction.

Masahiko Negishi, Kaoru Kobayashi, Tsutomu Sakuma, Tatsuya Sueyoshi

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Phenobarbital in Nuclear Receptor Activation: An Update.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Review
  14. Article
  15. Article
  16. Impact of Neonatal Activation of Nuclear Receptor CAR (Nr1i3) on Cyp2 Gene Expression in Adult Mouse Liver.Toxicological sciences : an official journal of the Society of Toxicology · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Masahiko NegishiPharmacogenetics Section, Reproductive and Developmental Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA. Electronic address: negishi@niehs.nih.gov.
Kaoru KobayashiDepartment of Biopharmaceutics, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan.
Tsutomu SakumaSchool of Pharmaceutical Sciences, Ohu University, Koriyama, Fukushima, Japan.
Tatsuya SueyoshiPharmacogenetics Section, Reproductive and Developmental Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA.
National Institutes of Health · USMeiji Pharmaceutical University · JPOhu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nuclear pregnane X receptor (PXR, NR1I2) and constitutive active/androstane receptor (CAR, NR1I3) are nuclear receptors characterized in 1998 by their capability to respond to xenobiotics and activate cytochrome P450 (

Indexed as

Signal TransductionAnimalsCytochrome P-450 Enzyme SystemPhosphorylationReceptors, Cytoplasmic and NuclearXenobioticsCytochrome P-450 Enzyme SystemReceptors, Cytoplasmic and NuclearXenobioticsCARcell signalingdrug metabolismestrogengene regulationinductionnuclear receptorNuclear receptorsphenobarbitalphosphorylationPXRsteroid hormone receptors

Identifiers

PMID32788213
PMCPMC7650254
OpenAlexW3048724268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.